Abcellera Biologics Inc (ABCL) financials · rev $12.4M
Abcellera Biologics Inc (ABCL) rev $12.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $75.1M | $28.8M |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$217.1M | -$314.8M |
| Net Income | -$146.4M | -$162.9M |
| EPS (Diluted) | $-0.49 | $-0.55 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.36B | $1.36B |
| Current Assets | $728.2M | $751.4M |
| Cash & Equivalents | $128.5M | $156.3M |
| Inventory | $6.3M | $0 |
| PP&E | $0 | $0 |
| Total Liabilities | $390.0M | $304.5M |
| Current Liabilities | $64.3M | $76.6M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $966.9M | $1.06B |
| Retained Earnings | -$29.5M | $116.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$131.3M | -$108.6M |
| CapEx | $42.8M | $78.4M |
| Investing Cash Flow | $87.8M | $121.4M |
| Financing Cash Flow | $14.1M | $12.8M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | -$28.4M | $23.0M |
| Free Cash Flow | -$174.1M | -$187.0M |
FAQ
What is ABCL P/E and revenue?
Abcellera Biologics Inc (ABCL) rev $12.4M.
What is ABCL revenue?
Abcellera Biologics Inc last cached revenue is $75.1M (FY2025).
Is ABCL profitable?
Abcellera Biologics Inc last cached net income is -$146.4M.
What are ABCL total assets?
Abcellera Biologics Inc last cached total assets are $1.36B.
What is ABCL free cash flow?
Abcellera Biologics Inc last cached free cash flow is -$174.1M.
Not investment advice. Cached statements, not a live tape.